The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

LAQ824 and LBH589 (panobinostat) are histone deacetylase inhibitors (HDACi) developed as cancer therapeutics and we have used the Eμ-myc lymphoma model to identify the molecular events required for their antitumor effects. Induction of tumor cell death was necessary for these agents to mediate thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Ellis, Leigh, Bots, Michael, Lindemann, Ralph K., Bolden, Jessica E., Newbold, Andrea, Cluse, Leonie A., Scott, Clare L., Strasser, Andreas, Atadja, Peter, Lowe, Scott W., Johnstone, Ricky W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580966/
https://ncbi.nlm.nih.gov/pubmed/19383971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-182758
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados